| ||
Name: 3-{(e)-2-[6-(cyclopropylamino)-9h-purin-9-yl]ethenyl}-4-methyl-n-[3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)phenyl]benzamide | ||
Formula: C29 H25 F3 N8 O | ||
Weight: 558.557 | ||
SMILES: "Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(C=Cn4cnc5c(NC6CC6)ncnc45)c3)cc(c2)C(F)(F)F" | ||
Spacial conformation based on PDB 3kfa |
RESIDUE B91 66 CONECT C1 3 N1 N6 C29 CONECT F1 1 C19 CONECT N1 3 C1 C3 C26 CONECT O1 1 C12 CONECT C2 4 C24 C28 H2 H2A CONECT F2 1 C19 CONECT N2 3 C12 C13 HN2 CONECT C3 3 N1 C4 H3 CONECT F3 1 C19 CONECT N3 3 C15 C22 C23 CONECT C4 3 C3 C5 H4 CONECT N4 2 C23 C25 CONECT C5 3 C4 C6 C10 CONECT N5 2 C26 C29 CONECT C6 3 C5 C7 C11 CONECT N6 2 C1 C33 CONECT C7 3 C6 C8 H7 CONECT N7 2 C30 C33 CONECT C8 3 C7 C9 H8 CONECT N8 3 C24 C30 HN8 CONECT C9 3 C8 C10 C12 CONECT C10 3 C5 C9 H10 CONECT C11 4 C6 H11 H11A H11B CONECT C12 3 O1 N2 C9 CONECT C13 3 N2 C14 C18 CONECT C14 3 C13 C15 H14 CONECT C15 3 N3 C14 C16 CONECT C16 3 C15 C17 H16 CONECT C17 3 C16 C18 C19 CONECT C18 3 C13 C17 H18 CONECT C19 4 F1 F2 F3 C17 CONECT C22 3 N3 C25 H22 CONECT C23 3 N3 N4 H23 CONECT C24 4 C2 N8 C28 H24 CONECT C25 3 N4 C22 C27 CONECT C26 3 N1 N5 H26 CONECT C27 4 C25 H27 H27A H27B CONECT C28 4 C2 C24 H28 H28A CONECT C29 3 C1 N5 C30 CONECT C30 3 N7 N8 C29 CONECT C33 3 N6 N7 H33 CONECT H2 1 C2 CONECT H2A 1 C2 CONECT HN2 1 N2 CONECT H3 1 C3 CONECT H4 1 C4 CONECT H7 1 C7 CONECT H8 1 C8 CONECT HN8 1 N8 CONECT H10 1 C10 CONECT H11 1 C11 CONECT H11A 1 C11 CONECT H11B 1 C11 CONECT H14 1 C14 CONECT H16 1 C16 CONECT H18 1 C18 CONECT H22 1 C22 CONECT H23 1 C23 CONECT H24 1 C24 CONECT H26 1 C26 CONECT H27 1 C27 CONECT H27A 1 C27 CONECT H27B 1 C27 CONECT H28 1 C28 CONECT H28A 1 C28 CONECT H33 1 C33 END HET B91 66 HETNAM B91 3-{(E)-2-[6-(cyclopropylamino)-9H-purin-9-yl]ethenyl}-4 HETNAM 2 B91 -methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluorome HETNAM 3 B91 thyl)phenyl]benzamide FORMUL B91 C29 H25 F3 N8 O1
This OCA
MONOMER page uses Jmol, developed by the Jmol Development Team (color reference)
|